Last reviewed · How we verify

NCT05078970: ASSIST

Advancing Suicide Intervention Strategies for Teens During High Risk Periods

Recruiting now NA Last updated 14 November 2025
What this trial tests

NA trial testing Safety Planning Intervention+ (SPI+) in Suicide Attempts in 306 participants. Currently enrolling.

Timeline
11 August 2022
Primary endpoint
31 January 2027
31 January 2027

Quick facts

Lead sponsorSeattle Children's Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment306
Start date11 August 2022
Primary completion31 January 2027
Estimated completion31 January 2027
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Seattle Children's Hospital

Who can join

Adults 11 to 17, any sex, with Suicide Attempts or Suicidal Ideation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To inform the effective management of adolescent suicide risk by evaluating promising treatments and developing the evidence-base for interventions that are well suited for widespread adoption, sustained quality, and impact.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Advancing Suicide Intervention Strategies for Teens (ASSIST): study protocol for a multisite randomised controlled trial.
    Adrian M, McCauley E, Gallop R, Stevens J, et al · · 2023 · cited 3× · PMID 38086585 · DOI 10.1136/bmjopen-2023-074116

Verify or expand the search:

Other recruiting trials for Suicide Attempts

Currently open trials in the same condition.

Other Seattle Children's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05078970.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing